Sano M et al. |
[Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration]. |
1994 |
Kansenshogaku Zasshi |
pmid:7829898
|
Sieber CC et al. |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?]. |
1994 |
Schweiz Med Wochenschr |
pmid:8091165
|
Terashima T et al. |
Pulmonary infection due to Mycobacterium xenopi. |
1994 |
Intern. Med. |
pmid:8000103
|
Dorrell L et al. |
Toxicity of clarithromycin in the treatment of Mycobacterium avium complex infection in a patient with AIDS. |
1994 |
J. Antimicrob. Chemother. |
pmid:7868416
|
Fish DN et al. |
Penetration of clarithromycin into lung tissues from patients undergoing lung resection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031063
|
Funke G et al. |
Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea. |
1994 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:7805694
|
Ishida K et al. |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031048
|
Shafran SD et al. |
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network. |
1994 |
N. Engl. J. Med. |
pmid:8284019
|
Meier A et al. |
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192472
|
Labenz J et al. |
[Omeprazole modified antibiotic therapy of Helicobacter pylori infection: can clarithromycin be replaced by roxithromycin?]. |
1994 |
Leber Magen Darm |
pmid:8196468
|
Chan GP et al. |
Clinical trial of clarithromycin for lepromatous leprosy. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203847
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Jones RN et al. |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. |
1994 |
Diagn. Microbiol. Infect. Dis. |
pmid:7924221
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
Tahara RW et al. |
The question of clarithromycin: a first-line drug for sinusitis? |
1994 |
Arch Fam Med |
pmid:7818657
|
Pustorino S et al. |
[Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group I pepsinogen]. |
1994 |
Clin Ter |
pmid:7820984
|
Alder J et al. |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. |
1994 |
J. Acquir. Immune Defic. Syndr. |
pmid:7932081
|
Ferrari SL et al. |
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. |
1994 |
Transplantation |
pmid:7940695
|
Tomono K |
[Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis]. |
1994 |
Kekkaku |
pmid:7837727
|
Sanchez T et al. |
Quantitation of mycobacteria in blood specimens from patients with AIDS. |
1994 |
Tuber. Lung Dis. |
pmid:7841433
|
Sungur C |
Acute rheumatic fever despite clarithromycin treatment of beta-hemolytic streptococcal tonsillitis. |
1994 |
Ann Pharmacother |
pmid:7841580
|
Maass M and Dalhoff K |
[Isolation of Chlamydia pneumoniae in atypical pneumonia]. |
1994 |
Dtsch. Med. Wochenschr. |
pmid:7956770
|
Verbist L and Dhoore F |
In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study. |
1994 |
Acta Clin Belg |
pmid:7871933
|
Wüst J and Hardegger U |
Penetration of clarithromycin into human saliva. |
1993 Sep-Oct |
Chemotherapy |
pmid:8370320
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Ohmori S et al. |
Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats. |
1993 Mar-Apr |
Drug Metab. Dispos. |
pmid:8097709
|
Wallace RJ et al. |
Drug intolerance to high-dose clarithromycin among elderly patients. |
1993 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:8477575
|
Adam D |
Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis. |
1993 Jul-Aug |
Infection |
pmid:8225636
|
Coles SJ et al. |
A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 Jul-Aug |
Infection |
pmid:8225637
|
Miller CA |
Infections, resistant microbes, and older adults. |
1993 Jan-Feb |
Geriatr Nurs |
pmid:8383085
|
Ritchie DJ et al. |
In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. |
1993 Jan-Feb |
Clin Ther |
pmid:8458040
|
Albani F et al. |
Clarithromycin-carbamazepine interaction: a case report. |
1993 Jan-Feb |
Epilepsia |
pmid:8422851
|
Sader HS et al. |
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. |
1993 Aug-Sep |
Diagn. Microbiol. Infect. Dis. |
pmid:8243035
|
Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Dautzenberg B et al. |
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. |
1993 |
Arch. Intern. Med. |
pmid:8427539
|
Chien SM et al. |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. |
1993 |
Chest |
pmid:8449054
|
Ji B et al. |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. |
1993 |
J. Infect. Dis. |
pmid:8257487
|
Scaglione F et al. |
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin. |
1993 |
J. Antimicrob. Chemother. |
pmid:8262876
|
Guay DR and Craft JC |
Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295810
|
Hebert AA et al. |
Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295811
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Lederer J et al. |
Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8414785
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
de Vega T et al. |
Clarithromycin-induced leukocytoclastic vasculitis. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8404922
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|